Monday, July 10, 2017

100 - Mega IPOs - out of vogue?

100 - Mega IPOs
- out of vogue?







Lotte Chemical Titan Holding Bhd's (LCT) ambitious mega plan to list its shares back on Bursa Malaysia after a seven year absence was given a wake-up call by the very poor response from the investing public, particularly the foreign funds.

Touted as one of Malaysia's biggest initial public offerings (IPOs) in recent years, it nearly didn't take off. The high pricing of RM8 per share and its too huge shares issuances sizes were too much for the investing groups to absorb.

It was after some 72 hours of tough re-negotiation again that finally a re-pricing and a reduced number of shares issuances agreement finally to see LCT on track for its listing debut.

Is the days of mad-scrambling for big reputation companies' Initial Public Offerings shares over? I do not have the answer. I can only point out to a few recent giant IPO that those who subscribed to their shares and stayed invested  until today will rue their actions sadly.

In 2012, palm oil firm Felda Global Ventures Holdings Bhd (FGV) listed at RM4.55 and surged to as high as RM5.46 bringing cheers to hundreds of thousands of plantation farmers and family members whom were offered guaranteed IPO shares. (Many must have taken bank loans to finance their IPO purchases. If they are still keeping the shares which most likely to do so, they are now face with a loan to service with interest yet their shares prices are down more than one dared to dream).

Since then, nothing has gone right for FGV and its shares price dropped to as low as RM1.18 on Aug 26, 2015. The share price is now at RM1.65.

In 2015, Malakoff Corp Bhd, a giant independent power producer to the country's main power company Tenaga Nasional Bhd (TNB), listed at RM1.80 Despite having a stable cash flow and a 70% dividend policy, its share price has not done well. It touched a low of RM1.02, incidentally at the time of writing on July 10, 2017.

For those employees at Malakoff with bank-financed loan for its IPO shares must be feeling gutted to be now, in debts and most probably cursing their position now. How to have motivation going to work everyday with such a situation?

More recently, this year In April, another very large IPO, Eco World International Bhd (Eco World) listed at RM1.20. But its share price even touched a low of RM1.00 and a high of RM1.36 since listing debut. Currently it is trading below its IPO price and closed at RM1.12. (The fortunate thing is the successful bidders for the IPO shares were given two free warrants for every five shares held after the IPO).

So why did all these mega companies flopped after making its listing debut? Save for Eco World's mild decline, the other two, FGV and Malakoff's declines are  sharply painful for the faithful subscribers or those who invested in the market directly and still holding on to their investments.

I think one reason must be the over valuations. It is common sense that if a company is going for listings, valuations play a very important role in determining the IPO price eventually. And this is where valuations come in.

The higher valuations accorded, the higher price will be offered to those who subscribed successfully. And the company would have collected its IPO proceeds regardless of what happens to its share price later.

Back to LCT, there are many puzzling questions that needed some answers. We can't blame the promoter of LCT for trying to price its valuation IPO price as high as possible. But what about the five cornerstone investors? The five : Permodolan Nasional Bhd (PNB), Maybank Asset Management Sdn Bhd, Maybank Islamic Management Sdn Bhd, Eastsprings Investments Bhd and Great Eastern Life Assurance (Malaysia), who agreed to acquire around 136 millions IPO shares (representing 18.4% of the base offering of the IPO).

Did these five companies with their huge resources and research investing team conduct any own analysis of LCT and arrived at their own valuations? If they have done so, then they must have arrived at a "surprisingly" collectively same valuations of LCT at this IPO price of RM8 per share.

I am sure if one of their research team had valued its IPO price at example below RM8, they would have advised their company about the difference and hence would have perhaps renegotiated with the  IPO promoter of LCT.

Remarkably, it needed the absence of interest to subscribe for the portion from all those foreign funds that set up the alarm bell. Thus the promoters had to reprice the share from RM8 to RM6.50 which is a big discount of around 18% and also cut the numbers of shares issuance by one-fifth.

At this adjusted price of RM6.50, I think the valuation of LCT would have be at a price earnings ratio of 20 (based on its net profit of RM1.3bil). This is also considered on the high side unless the market perceived LCT as another premium chemical player which deserved a higher PE ratings. The other is Petronas Chemicals Group Bhd (PetChem) which is trading at a PE of around 19.

But of course by the time you are reading this, LCT would have made its debut on Bursa Malaysia on July 11th and market would have its own natural mechanism of trading between buyers and sellers to determine the price again.

Mr Market will deliver its verdict today!




Monday, July 3, 2017

99 - Luxchem continues to grow

99 - Luxchem continues
to grow



Demand for glove will always be there as long as world population continue to grow. Because glove is one area the medical industry will continue to need to use.

The products are often either necessary or mandatory and therefore the industry is inherently resilient. That means demand will stay firm no matter how severely people slash their spending. It is widely believed that the demand for glove is growing at 10% per annum.

I realised the extend of such demand for usage for glove when during my last few visits to several different private hospitals and on the movable side table was a box of gloves - ever ready to be used especially by the attending nurses or doctors. And each time after a usage, the glove is disposed and a new one is required for the next usage.

No wonder the big four King glove manufacturers of Malaysia, Kossan Rubber Industries Bhd, Supermax Corp Bhd, Top Glove Corp Bhd and Hartalega Holdings Bhd continue to expand their capacities over the years.

Business is so good for them that if one is a very early bird investors of these four companies, one would have reaped massive returns on their investments to date.

As latex is required in the process of manufacturing the glove, one small low profile company that has been quietly supplying the big glove industry is chemical supplier, Luxchem Corporation Berhad.

Luxchem being an industrial chemical supplier focuses on several industries' needs - rubber, latex (glove), fiberglass reinforced plastic, coating, ceramic and polyvinyl chloride.

Luxchem's businesses are divided into two segments i.e. Trading (79.6%) and Manufacturing (20.45). Revenue from the Malaysian market is 70% with the balance from export market.

Realising that the Malaysia market is perhaps at a saturating point, it ventured into Indonesia in 2011 and further into Vietnam in 2015. I think the management of Luxchem must have seen that Indonesia and Vietnam, both with a population of 263 million and 95 million respectively (compared to 30 million for Malaysia) presented a very big growing market to tap.

Its overseas ventured seemed to have paid off so far. Its Indonesian market contributed 15% of trading segment revenue for Financial Year ending 2016 while its manufacturing segment did even better. Export sales contributed 84% from countries such as Vietnam, Thailand, Bangladesh, Australia and Singapore.

The, the acquisition of Transform Master Sdn Bhd in 2016 helped to kick start an impressive 1st Quarter 2017 results with revenue increasing by 36% to RM 218 million and net profits jumped to RM13.6 million which is an remarkable 94% increase!

Luxchem will continue to focus on high-growth export markets such as Indonesia and Vietnam which collectively account for 23.9% of its revenue base (FY2016). And its revenue continues to grow impressively.

Consistently rewarding shareholders
with good dividends

Luxchem is also another stock that consistently rewards its shareholders with dividends that can match the fixed deposits by the banks. Since its listing debut on the Main Board of Bursa Malaysia in June 2008, it has paid out dividends every year without fail, thanks to its consistent earnings too.





Early bird investors who had subscribed to its IPO at RM1.10 and dared to hold on until today would have seen their investments ballooned to nearly 300% based on the current price of RM2 plus level, and this does not take into consideration the total dividends of RM785 (from Year 2008 to 2016).

There wasn't much coverage on Luxchem initially after its listing in 2008.
There were the occasional reports or blogs written about Luxchem. But what caught my attention to invest in Luxchem shares is its steady results and its slow but gradual rise in dividends payout ratio.

And I am the type of investors who likes to invest in this type of simple to understand yet very focussed minded business company yet boring but a very steady paying dividends stock.

After some deeply reviews of pros and cons, yours truly decided to invest in Luxchem shares at RM1.18 on May 11, 2012 and again at RM1.19 on May 29, 2012. Since then, it has turned out to be one of my best performing stocks I have ever invested. I am glad I have been daring enough to hold on until today because there were many instances I was very tempted to sell off for profits, but the main reasons were it has been steadying paying good dividends twice a year consistently.

Why sell off a growing golden goose when it gives you golden eggs twice a year, year after year?